Skip to main content
VCbacked
Log inGet Started

Novel Microdevices

Baltimore, United States

Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.

$1.0M raised
Apr 2026
Convertible Note
BiotechnologyHealth CareMedicalMedical Device

Top Investors

TEDCOCARB-XNational Institutes of HealthMaryland Department of Commerce

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Novel Microdevices

How much funding has Novel Microdevices raised?
Novel Microdevices has raised $1.0M in total funding. The most recent round was Convertible Note. The last funding was announced in April 2026.
Who are Novel Microdevices's investors?
Novel Microdevices's investors include TEDCO, CARB-X, National Institutes of Health, Maryland Department of Commerce.
Where is Novel Microdevices headquartered?
Novel Microdevices is headquartered in Baltimore, United States.
What does Novel Microdevices do?
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
What stage is Novel Microdevices at?
Novel Microdevices is at the Convertible Note stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Novel Microdevices — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/novel-microdevices. Accessed July 4, 2026.
APA
VCBacked. (2026). Novel Microdevices — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/novel-microdevices
Wikipedia (cite web)
{{cite web |title=Novel Microdevices — Funding & Investors |url=https://www.vcbacked.co/company/novel-microdevices |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K